CSIMarket
 


Oncomed Pharmaceuticals Inc  (OMED)
Other Ticker:  
 


Oncomed Pharmaceuticals Inc's Operating Profit Margin by quarter

Trends, Rankings, Statistics



OMED Operating Profit Margin (Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Revenue Change -42.11 % 282.26 % 10.9 % 26.33 % 231.89 %
Seq. Revenue Change -38.78 % 184.1 % -12.47 % -61.97 % 304.23 %
Revenue In Millions $11.95 $19.52 $6.87 $7.85 $20.64
Operating Profit Margin 9.38 % 29.67 % -71.15 % -75.58 % 39.95 %
Operating Profit Margin Total Ranking # 1929 # 771 # # # 516
Operating Income In Millions $1.12 $5.79 $-4.89 $-5.93 $8.25
Y / Y Operating Income Change -86.4 % - - - -
Seq. Operating Income Change -80.64 % - - - -


Commenting fourth Quarter 2018 Operating Profit Margin
Oncomed Pharmaceuticals Inc experienced contraction in Operating Income by -80.64 % to $12 millions and Revenue by -38.78 %, while Operating Profit Margin fell to 9.38 % a new company low.

Observing fourth quarter 2018 results within Major Pharmaceutical Preparations industry 52 other companies have achieved higher Operating Profit Margin. While Operating Profit Margin overall ranking has deteriorated compare to previous quarter from 771 to 1929.
Explain Operating Margin
OMED's Operating Profit Margin fourth quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 53
Healthcare Sector # 142
Overall # 1886

Operating Profit Margin Statistics
High Average Low
39.95 % 26.33 % 9.38 %
(Dec 31 2017)   (Dec 31 2018)




Other Operating Profit Margin Profitability Ratios
OMED's Cumulative Operating Profit Margin
Major Pharmaceutical Preparations Industry Operating Profit Margin Trends and Statistics
Healthcare Sector Operating Profit Margin Statistics
Operating Profit Margin Profitability Trends for overall market
OMED's Operating Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Profit Margin
Lowest Ranking Operating Profit Margin
Operating Profit Margin Profit Margin for OMED's Competitors
Operating Profit Margin Profit Margin for Oncomed Pharmaceuticals Inc's Suppliers
Operating Profit Margin Profit Margin for OMED's Customers

You may also want to know
OMED's Annual Growth Rates OMED's Profitability Ratios OMED's Asset Turnover Ratio OMED's Dividend Growth
OMED's Roe OMED's Valuation Ratios OMED's Financial Strength Ratios OMED's Operating Income Growth
OMED's Roa OMED's Inventory Turnover Ratio OMED's Growth Rates OMED's Dividend Comparisons


Companies with similar Operating Profit Margin in the quarter ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Operating Profit MarginDec 31 2018 MRQ Operating IncomeDec 31 2018 MRQ Revenue
Merck and Co Inc   24.68 %$ 2,714.000 $ 10,998.000 
Zoetis Inc   24.63 %$ 418.000 $ 1,697.000 
Johnson and Johnson  20.37 %$ 4,154.000 $ 20,394.000 
Ani Pharmaceuticals Inc  20.04 %$ 11.445 $ 57.122 
Sinovac Biotech Ltd  19.73 %$ 45.316 $ 229.650 
Cv Sciences Inc   19.38 %$ 2.756 $ 14.224 
Fibrogen Inc   18.43 %$ 19.919 $ 108.054 
Pacira Biosciences inc   17.88 %$ 19.883 $ 111.228 
Gsk Plc  17.79 %$ 5,483.000 $ 30,821.000 
Vanda Pharmaceuticals Inc   17.25 %$ 9.150 $ 53.041 
Pfizer Inc  16.54 %$ 2,312.000 $ 13,977.000 
Novartis Ag  15.37 %$ 8,169.000 $ 53,166.000 
Abbott Laboratories  15.00 %$ 1,165.000 $ 7,765.000 
Collegium Pharmaceutical Inc   14.98 %$ 11.001 $ 73.427 
Cambrex Corp  14.76 %$ 19.831 $ 134.332 
Vertex Pharmaceuticals Inc  14.68 %$ 127.722 $ 870.106 
Sanofi  13.11 %$ 5,237.120 $ 39,958.240 
Catalent Inc   12.55 %$ 78.200 $ 623.000 
Phibro Animal Health Corporation  11.78 %$ 25.706 $ 218.223 
Amneal Pharmaceuticals Inc   11.24 %$ 86.834 $ 772.717 
Oncomed Pharmaceuticals Inc  9.38 %$ 1.121 $ 11.948 
Deciphera Pharmaceuticals Inc   9.30 %$ 2.552 $ 27.432 
Mylan N v   7.56 %$ 232.800 $ 3,078.700 
Ionis Pharmaceuticals Inc  5.61 %$ 10.782 $ 192.113 
Ironwood Pharmaceuticals inc   4.59 %$ 5.995 $ 130.692 
Eli Lilly And Company  4.42 %$ 315.500 $ 7,135.800 
Emergent Biosolutions Inc   4.14 %$ 11.199 $ 270.733 
Integrated Biopharma Inc  4.06 %$ 0.487 $ 12.001 
Alexion Pharmaceuticals Inc   3.87 %$ 43.700 $ 1,128.800 
Eterna Therapeutics Inc   2.93 %$ 0.173 $ 5.903 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com